Abstract
Bone cells communicate with each other using various cell surface molecules. Membrane-bound ephrin ligands and Eph tyrosine kinase receptors have been characterized in diverse biological processes, including angiogenesis and neuronal development. Several ephrins and Ephs are expressed in osteoclasts and osteoblasts and regulate bone mineral metabolism through bidirectional signaling into not only receptor-expressing cells but also into ligand-expressing cells. We propose that interaction between ephrinB2-expressing osteoclasts and EphB4-expressing osteoblasts facilitates the transition from bone resorption to bone formation during bone remodeling. Other groups have reported the regulation of ephrinB2 by PTH or PTHrP and the possible involvement of EphB4 in osteoarthritis. It is likely that various ephrins and Ephs mediate interaction among bone cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allan, E. H., Hausler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S. et al. (2008). EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res, 23, 1170–1181.
Compagni, A., Logan, M., Klein, R., & Adams, R. H. (2003). Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell, 5, 217–230.
Davy, A., Bush, J. O., & Soriano, P. (2006). Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol, 4, e315.
Edwards, C. M., & Mundy, G. R. (2008). Eph receptors and ephrin signaling pathways: a role in bone homeostasis. Int J Med Sci, 5, 263–272.
Eph Nomenclature Committee (1997). Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell, 90, 403–404.
Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998). TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med, 188, 997–1001.
Harmey, D., Stenbeck, G., Nobes, C. D., Lax, A. J., & Grigoriadis, A. E. (2004). Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res, 19, 661–670.
Hattner, R., Epker, B. N., & Frost, H. M. (1965). Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature, 206, 489–490.
Irie, N., Takada, Y., Watanabe, Y., Matsuzaki, Y., Naruse, C., Asano, M., Iwakura, Y. Sudha, T., & Matsuo, K. (2009). Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem, 284, 14637–14644.
Ishii, M., Egen, J. G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R.L., & Germain, R. N. (2009). Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature, 458, 524–528.
Kim, I., Ryu, Y. S., Kwak, H. J., Ahn, S. Y., Oh, J. L., Yancopoulos, G. D. et al. (2002). EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. Faseb J, 16, 1126–1128.
Kim, Y., Sato, K., Asagiri, M., Morita, I., Soma, K., & Takayanagi, H. (2005). Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem, 280, 32905–32913.
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E. et al. (2004). Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature, 428, 758–763.
Korff, T., Braun, J., Pfaff, D., Augustin, H. G., & Hecker, M. (2008). Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood, 112, 73–81.
Kuroda, C., Kubota, S., Kawata, K., Aoyama, E., Sumiyoshi, K., Oka, M. et al. (2008). Distribution, gene expression, and functional role of EphA4 during ossification. Biochem Biophys Res Commun, 374, 22–27.
Kwan Tat, S., Pelletier, J. P., Amiable, N., Boileau, C., Lajeunesse, D., Duval, N., & Martel-Pelletier, J. (2008). Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum, 58, 3820–3830.
Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T. et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93, 165–176.
Matsuo, K., & Irie, N. (2008). Osteoclast-osteoblast communication. Arch Biochem Biophys, 473, 201–209.
Matsuo, K., & Ray, N. (2004). Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. Keio J Med, 53, 78–84.
McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell, 6, 483–495.
Mundy, G. R., & Elefteriou, F. (2006). Boning up on ephrin signaling. Cell, 126, 441–443.
Pasquale, E. B. (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell, 133, 38–52.
Pelletier, J. P., Boileau, C., Brunet, J., Boily, M., Lajeunesse, D., Reboul, P., Laufer, S., & Martel-Pelletier, J. (2004). The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone, 34, 527–538.
Pfaff, D., Heroult, M., Riedel, M., Reiss, Y., Kirmse, R., Ludwig, T., Korff, T., Hecker, M., & Augustin, H. G. (2008). Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J Cell Sci, 121, 3842–3850.
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988). Osteoblastic cells are involved in osteoclast formation. Endocrinology, 123, 2600–2602.
Twigg, S. R., Kan, R., Babbs, C., Bochukova, E. G., Robertson, S. P., Wall, S. A., Morriss-Kay, G. M., & Wilkie, A. O. (2004). Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A, 101, 8652–8657.
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S. et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A, 95, 3597–3602.
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K.(2006). Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab, 4,111–121.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Matsuo, K. (2009). Eph and Ephrin Interactions in Bone. In: Choi, Y. (eds) Osteoimmunology. Advances in Experimental Medicine and Biology, vol 658. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1050-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1050-9_10
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1049-3
Online ISBN: 978-1-4419-1050-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)